Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
The Journal of Pharmacology and Experimental Therapeutics|May 23, 2002
Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptorJan Jakubík, Stanislav Tucek, Esam E El-FakahanyBiochemical Pharmacology|August 31, 2025
Cholesterol differentially modulates the activity of opioid and muscarinic receptors via a common binding siteNikolai Chetverikov, Alena Janoušková-Randáková, Dominik Nelic, et al.British Journal of Pharmacology|July 11, 2026
Dualsteric and dual-acting modulation of muscarinic receptors by antagonist KH-5Alena Janoušková-Randáková, Eva Dolejší, Nikolai Chetverikov, et al.BMC Pharmacology|December 30, 2009
Divergence of allosteric effects of rapacuronium on binding and function of muscarinic receptorsJan Jakubík, Alena Randáková, Esam E El-Fakahany, et al.British Journal of Pharmacology|March 3, 2018
Novel long-acting antagonists of muscarinic ACh receptorsAlena Randáková, Vladimír Rudajev, Vladimír Doležal, et al.Plos One|February 22, 2014
Long-term activation upon brief exposure to xanomleline is unique to M1 and M4 subtypes of muscarinic acetylcholine receptorsEva Šantrůčková, Vladimír Doležal, Esam E El-Fakahany, et al.Plos One|March 28, 2019
Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulatorsJan Jakubík, Alena Randáková, Esam E El-Fakahany, et al.International Journal of Molecular Sciences|November 11, 2022
Allosteric Modulation of Muscarinic Receptors by Cholesterol, Neurosteroids and Neuroactive SteroidsEwa Szczurowska, Eszter Szánti-Pintér, Alena Randáková, et al.Scientific Reports|September 4, 2020
The operational model of allosteric modulation of pharmacological agonismJan Jakubík, Alena Randáková, Nikolai Chetverikov, et al.Plos One|November 24, 2011
Subtype differences in pre-coupling of muscarinic acetylcholine receptorsJan Jakubík, Helena Janíčková, Alena Randáková, et al.Pageof 4